Advancing RNA manufacturing worldwide
Press releases
Stay up to date with Hongene’s latest developments — from new technologies and product launches to scientific publications, industry recognition and global events. Discover how we are advancing nucleic acid manufacturing and supporting partners across oligonucleotide and mRNA development.
Aug 15, 2021
News
Hongene Launches Operations at its New mRNA CDMO GMP Facility
Dec 12, 2020
News
Hongene Expands Phosphoramidite Production Capability to 58(t).
Reviewed by David Butler, Chief Technology Officer at Hongene.
David has 20 years of experience in oligonucleotide therapeutics, with leadership roles at Korro Bio, Alltrna, Wave Life Sciences, and Alnylam Pharmaceuticals. He specialises in RNA drug development, LNP delivery technologies, and scalable oligonucleotide manufacturing.
Last reviewed: 17/04/2026